Pre- or post-menopausal women with impairments in DNA repair due to germline BRCA1/2 mutations may be more suceptible to the pro-mutagenic and pro-proliferative effects of free estrogens, which could lead to increased breast cancer risk. Here, BRCA1 is linked to breast carcinoma.